Can people with cardiomyopathy eat beef?

Written by Zhang Yue Mei
Cardiology
Updated on September 23, 2024
00:00
00:00

Patients with myocarditis can eat beef, but not too much. They should consume beef in small amounts. Beef is a type of meat with very high nutritional value, and it is a major source of high-quality protein, trace elements, and minerals for the human body. Eating beef regularly can improve the body's immunity and disease resistance. For patients with myocarditis, eating beef can help accelerate the repair of myocardial tissue. However, it is advisable not to eat fatty beef but instead choose lean meat and consume it in moderation. It is also important to pay attention to dietary structure, preferably eating easily digestible, high-protein nutritional foods, and increase the intake of vegetables and fruits, which can aid in the recovery from myocarditis.

Other Voices

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
51sec home-news-image

What should I do if dilated cardiomyopathy is causing insomnia?

Dilated cardiomyopathy causing insomnia needs to be treated based on the cause of the insomnia. First, if it is simply poor sleep quality causing occasional insomnia, no special treatment is needed. However, if insomnia occurs daily and affects quality of life, sleep-improving medications such as eszopiclone or zopiclone may be taken under a doctor's guidance. Second, if caused by worsening heart failure symptoms, which lead to nocturnal respiratory distress and affect sleep, resulting in insomnia, the treatment for heart failure should be intensified under a doctor's guidance, for instance, by increasing diuretic treatment or adjusting medications. Improving heart failure symptoms naturally enhances sleep quality. (If medication is required, please do so under the guidance of a doctor)

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 38sec home-news-image

How is hypertrophic cardiomyopathy treated?

The treatment of hypertrophic cardiomyopathy aims to improve symptoms, reduce complications, and prevent sudden death. The methods include improving ventricular compliance by reducing outflow tract obstruction, preventing thromboembolic events, and identifying high-risk patients for sudden death. Treatment needs to be individualized, and the main treatments include the following aspects: 1. Medication treatment. Drug treatment is fundamental, and drugs targeting outflow tract obstruction mainly include receptor blockers and non-dihydropyridine calcium channel blockers. For patients with congestive heart failure, targeted treatment is required. Anticoagulation treatment is necessary for patients with atrial fibrillation, and it is worth noting that for patients with chest discomfort, care should be taken to exclude outflow tract obstruction when using nitrate drugs to avoid exacerbation after use. Non-drug treatments include: 1. Surgical treatment: For patients with ineffective drug treatment and heart function class three to four, if there is severe outflow tract obstruction, septal myectomy should be considered. Currently, surgery is listed as the preferred treatment for suitable patients in consensus guidelines in both America and Europe. 2. Alcohol septal ablation; 3. Pacing therapy.

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
54sec home-news-image

Can myocarditis cause dizziness?

Cardiomyopathy is a fairly common disease in our daily lives. From a medical perspective, cardiomyopathy can usually be divided into dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, and restrictive cardiomyopathy. When cardiomyopathy is present for a long time, it may cause a decline in the heart’s pumping function, leading to a reduction in cardiac output and resulting in heart failure. In such cases, due to insufficient blood supply to the brain, patients often experience symptoms of dizziness. If diagnosed with cardiomyopathy, under the guidance of a doctor, regulated medication can often significantly improve symptoms, including dizziness. (Specific medication usage should be conducted under the guidance of a doctor; do not self-medicate.)

doctor image
home-news-image
Written by Zhang Yue Mei
Cardiology
45sec home-news-image

Is cardiomyopathy life-threatening?

Whether cardiomyopathy poses a threat to life depends on the severity of the condition. Mild myocardial damage, if detected early, diagnosed early, and treated with effective medications in a timely manner, generally has a good prognosis, poses no threat to life, and leaves no sequelae. Severe myocardial damage, due to lack of timely treatment, can lead to serious complications such as heart failure, arrhythmias, and cardiogenic shock, which can endanger life safety. Therefore, early diagnosis, early treatment, and prevention of complications are crucial treatment measures for cardiomyopathy.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 15sec home-news-image

Treatment of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, due to unknown causes and often related to genetic factors, is difficult to prevent. It is important to guide patients on how to lead their lives, reminding them to avoid intense physical activities, heavy lifting, or breath-holding to reduce the incidence of sudden death. Avoid using drugs that enhance myocardial contractility and reduce cardiac capacity load, such as digoxin and nitrates, to decrease the aggravation of left ventricular outflow tract obstruction. The treatment principle for this disease is to slow down the hypertrophy of the myocardium, prevent tachycardia, and maintain normal sinus rhythm. It also aims to relieve the narrowing of the left ventricular outflow tract and counteract arrhythmias. Currently, the use of beta blockers and calcium channel blockers is advocated. For severe obstructive patients, interventional and surgical treatments can be carried out, including the implantation of a dual-chamber DTD pacemaker, and the ablation or removal of hypertrophied interventricular septum myocardium.